Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links

References

• McFarlaneSIMuniyappaRShinJJBahtiyarGSowersJROsteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?Endocrine200423111015034190
   PubMed Web of Science ®Google Scholar
• SinnottBSyedISevrukovABarengoltsECoronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with agingCalcif Tissue Int200678419520216604285
   PubMed Web of Science ®Google Scholar
• FarhatGNCauleyJAThe link between osteoporosis and cardiovascular diseaseClin Cases Miner Bone Metab200851193422460842
   PubMedGoogle Scholar
• LampropoulosCEPapaioannouID’CruzDPOsteoporosis – a risk factor for cardiovascular disease?Nat Rev Rheumatol201281058759822890244
   PubMed Web of Science ®Google Scholar
• ThompsonBTowlerDAArterial calcification and bone physiology: role of the bone-vascular axisNat Rev Endocrinol20128952954322473330
   PubMed Web of Science ®Google Scholar
• CrepaldiGMaggiSEpidemiologic link between osteoporosis and cardiovascular diseaseJ Endocrinol Invest200932Suppl 42519724158
   PubMedGoogle Scholar
• FarhatGNNewmanABSutton-TyrrellKThe association of bone mineral density measures with incident cardiovascular disease in older adultsOsteoporos Int2007187999100817285350
   PubMed Web of Science ®Google Scholar
• SzulcPSamelsonEJKielDPDelmasPDIncreased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS studyJ Bone Miner Res200924122023203119453264
   PubMed Web of Science ®Google Scholar
• HyderJAAllisonMAWongNAssociation of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium StudyAm J Epidemiol2009169218619419064643
   PubMed Web of Science ®Google Scholar
• ChoiSHAnJHLimSLower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre-and postmenopausal womenClin Endocrinol (Oxf)200971564465119226260
   PubMed Web of Science ®Google Scholar
• MussolinoMEMadansJHGillumRFBone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up studyAnn Epidemiol2003131069269714599733
   PubMed Web of Science ®Google Scholar
• MussolinoMEMadansJHGillumRFBone mineral density and strokeStroke2003345e20e2212663880
   PubMed Web of Science ®Google Scholar
• ChenJSHoganCLyubomirskyGSambrookPNWomen with cardiovascular disease have increased risk of osteoporotic fractureCalcif Tissue Int201188191521046091
   PubMed Web of Science ®Google Scholar
• den UylDNurmohamedMTvan TuylLHRatermanHGLemsWF(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosisArthritis Res Ther2011131R521241491
   PubMed Web of Science ®Google Scholar
• LyonsKJMajumdarSREzekowitzJAThe unrecognized burden of osteoporosis-related vertebral fractures in patients with heart failureCirc Heart Fail20114441942421558449
   PubMed Web of Science ®Google Scholar
• SennerbyUMelhusHGedeborgRCardiovascular diseases and risk of hip fractureJAMA2009302151666167319843901
   PubMed Web of Science ®Google Scholar
• BakhirevaLNBarrett-ConnorELLaughlinGAKritz-SilversteinDDifferences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo StudyMenopause200512669169816278612
   PubMed Web of Science ®Google Scholar
• MussolinoMEArmenianHKLow bone mineral density, coronary heart disease, and stroke mortality in men and women: the Third National Health and Nutrition Examination SurveyAnn Epidemiol2007171184184617728148
   PubMed Web of Science ®Google Scholar
• SamelsonEJCupplesLABroeKEHannanMTO’DonnellCJKielDPVascular calcification in middle age and long-term risk of hip fracture: the Framingham StudyJ Bone Miner Res20072291449145417542685
   PubMed Web of Science ®Google Scholar
• HolickMFVitamin D: evolutionary, physiological and health perspectivesCurr Drug Targets201112141820795941
   PubMed Web of Science ®Google Scholar
• LeeJHGadiRSpertusJATangFO’KeefeJHPrevalence of vitamin D deficiency in patients with acute myocardial infarctionAm J Cardiol2011107111636163821439530
   PubMed Web of Science ®Google Scholar
• WangTJPencinaMJBoothSLVitamin D deficiency and risk of cardiovascular diseaseCirculation2008117450351118180395
   PubMed Web of Science ®Google Scholar
• de BoerIHKestenbaumBShobenABMichosEDSarnakMJSiscovickDS25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcificationJ Am Soc Nephrol20092081805181219443637
   PubMed Web of Science ®Google Scholar
• DobnigHPilzSScharnaglHIndependent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortalityArch Intern Med2008168121340134918574092
   PubMed Web of Science ®Google Scholar
• GiovannucciELiuYHollisBWRimmEB25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective studyArch Intern Med2008168111174118018541825
   PubMedGoogle Scholar
• MelamedMLMichosEDPostWAstorB25-Hydroxyvitamin D levels and the risk of mortality in the general populationArch Intern Med2008168151629163718695076
   PubMed Web of Science ®Google Scholar
• AnderssonPRydbergEWillenheimerRPrimary hyperparathyroidism and heart disease – a reviewEur Heart J200425201776178715474692
   PubMed Web of Science ®Google Scholar
• Garcia de la TorreNWassJATurnerHEParathyroid adenomas and cardiovascular riskEndocr Relat Cancer200310230932212790792
   PubMed Web of Science ®Google Scholar
• HagströmEHellmanPLarssonTEPlasma parathyroid hormone and the risk of cardiovascular mortality in the communityCirculation2009119212765277119451355
   PubMed Web of Science ®Google Scholar
• HagströmEIngelssonESundströmJPlasma parathyroid hormone and risk of congestive heart failure in the communityEur J Heart Fail201012111186119220797986
   PubMed Web of Science ®Google Scholar
• JordeRSvartbergJSundsfjordJSerum parathyroid hormone as a predictor of increase in systolic blood pressure in menJ Hypertens20052391639164416093907
   PubMed Web of Science ®Google Scholar
• SchierbeckLLJensenTSBangUJensenGKøberLJensenJEParathyroid hormone and vitamin D – markers for cardiovascular and all cause mortality in heart failureEur J Heart Fail201213662663221415099
   PubMed Web of Science ®Google Scholar
• SugimotoTTanigawaTOnishiKSerum intact parathyroid hormone levels predict hospitalisation for heart failureHeart200995539539819001003
   PubMed Web of Science ®Google Scholar
• GrandiNCBreitlingLPHahmannHSerum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart diseaseHeart201197151215122121586795
   PubMed Web of Science ®Google Scholar
• GrandiNCBreitlingLPVossenCYSerum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart diseaseAm Heart J201015961044105120569718
   PubMed Web of Science ®Google Scholar
• GrandiNCBrennerHHahmannHCalcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart diseaseHeart2012981292693322301505
   PubMed Web of Science ®Google Scholar
• DhingraRSullivanLMFoxCSRelations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the communityArch Intern Med2007167987988517502528
   PubMed Web of Science ®Google Scholar
• OnufrakSJBellasiACardarelliFInvestigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortalityAm J Epidemiol20091691677718980959
   PubMed Web of Science ®Google Scholar
• OnufrakSJBellasiAShawLJPhosphorus levels are associated with subclinical atherosclerosis in the general populationAtherosclerosis2008199242443118093595
   PubMed Web of Science ®Google Scholar
• PalmerSCHayenAMacaskillPSerum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysisJAMA2011305111119112721406649
   PubMed Web of Science ®Google Scholar
• GoliaschGBlessbergerHAzarDMarkers of bone metabolism in premature myocardial infarction (</= 40 years of age)Bone201148362262621078422
   PubMed Web of Science ®Google Scholar
• PennisiPRussoEGaudioAThe association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?Maturitas201167435836220727694
   PubMed Web of Science ®Google Scholar
• SambrookPNChenCJMarchLHigh bone turnover is an independent predictor of mortality in the frail elderlyJ Bone Miner Res200621454955516598375
   PubMed Web of Science ®Google Scholar
• SembAGUelandTAukrustPOsteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993–2003Arterioscler Thromb Vasc Biol200929697598019325145
   PubMed Web of Science ®Google Scholar
• YeapBBChubbSAFlickerLAssociations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men StudyOsteoporos Int201223259960621359669
   PubMed Web of Science ®Google Scholar
• TanAGaoYYangXLow serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population surveyMetabolism20116081186119221353261
   PubMed Web of Science ®Google Scholar
• MaderoMWasselCLPeraltaCAMarkers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition studyAm J Hypertens201124775576121436791
   PubMed Web of Science ®Google Scholar
• Robinson-CohenCKatzRHoofnagleANMineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health studyJ Clin Endocrinol Metab20119672186219321508146
   PubMed Web of Science ®Google Scholar
• TaylorENRimmEBStampferMJCurhanGCPlasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart diseaseAm Heart J2011161595696221570529
   PubMed Web of Science ®Google Scholar
• ParkerBDBauerDCEnsrudKEIxJHAssociation of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fracturesCalcif Tissue Int201086318519120094707
   PubMed Web of Science ®Google Scholar
• CameronIDChenJSMarchLMHip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year studyJ Bone Miner Res201025486687219839771
   PubMed Web of Science ®Google Scholar
• DabanJLDe Saint MauriceGPBatjomEFalzoneEAussetSPostoperative myocardial damages are a key issue in patients’ outcome after hip fractureAge Ageing2009384488489 author reply 48919411672
   PubMed Web of Science ®Google Scholar
• Dawson-BowlingSChettiarKCottamHTroponin T as a predictive marker of morbidity in patients with fractured neck of femurInjury200839777578018407276
   PubMed Web of Science ®Google Scholar
• LeveyASStevensLASchmidCHA new equation to estimate glomerular filtration rateAnn Intern Med2009150960461219414839
   PubMed Web of Science ®Google Scholar
• GarneroPBiomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoringMol Diagn Ther200812315717018510379
   PubMed Web of Science ®Google Scholar
• IkegamiSKamimuraMUchiyamaSKatoHWomen with insufficient 25-hydroxyvitamin D without secondary hyperparathyroidism have altered bone turnover and greater incidence of vertebral fracturesJ Orthop Sci201116557358021713425
   PubMed Web of Science ®Google Scholar
• GarneroPBauerDCMareauEEffects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH studyJ Bone Miner Res20082391442144818442311
   PubMed Web of Science ®Google Scholar
• GarneroPHausherrEChapuyMCMarkers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective StudyJ Bone Miner Res19961110153115388889854
   PubMed Web of Science ®Google Scholar
• CoenGMantellaDCalabriaSUrinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failureAm J Nephrol200020428329010970981
   PubMed Web of Science ®Google Scholar
• LarocheMHeterogeneity of biological bone markers in idiopathic male osteoporosisRheumatol Int20123272101210421499877
   PubMed Web of Science ®Google Scholar
• ColwellAEastellRThe renal clearance of free and conjugated pyridinium cross-links of collagenJ Bone Miner Res19961112197619808970901
   PubMed Web of Science ®Google Scholar
• AponeSLeeMYEyreDROsteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human boneBone19972121291369267687
   PubMed Web of Science ®Google Scholar
• LipsPvan SchoorNMThe effect of vitamin D on bone and osteoporosisBest Pract Res Clin Endocrinol Metab201125458559121872800
   PubMed Web of Science ®Google Scholar
• SahotaOGaynorKHarwoodRHHoskingDJHypovitaminosis D and ‘functional hypoparathyroidism’ – the NoNoF (Nottingham Neck of Femur) studyAge Ageing200130646747211742774
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHAWillettWCOravEJA pooled analysis of vitamin D dose requirements for fracture preventionN Engl J Med20123671404922762317
   PubMed Web of Science ®Google Scholar
• SahotaOMundeyMKSanPGodberIMLawsonNHoskingDJThe relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosisBone200435131231915207772
   PubMed Web of Science ®Google Scholar
• SakumaMEndoNOinumaTVitamin D and intact PTH status in patients with hip fractureOsteoporos Int200617111608161416874442
   PubMed Web of Science ®Google Scholar
• AmouzouganAChopinFLaporteSVicoLThomasTFunctional hypoparathyroidism in postmenopausal women with fragility fractureJoint Bone Spine201279217017521664167
   PubMed Web of Science ®Google Scholar
• MadsenCMJorgensenHLLindBSecondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practiceInjury20124371052105722261083
   PubMed Web of Science ®Google Scholar
• BjorkmanMPSorvaAJRisteliJTilvisRSLow parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiencyJ Am Geriatr Soc20095761045105019473453
   PubMed Web of Science ®Google Scholar
• FisherASrikusalanukulWDavisMSmithPHip fracture type: important role of parathyroid hormone (PTH) response to hypovitaminosis DBone201047240040720451678
   PubMed Web of Science ®Google Scholar
• von MuhlenDGGreendaleGAGarlandCFWanLBarrett-ConnorEVitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo StudyOsteoporos Int200516121721172615928802
   PubMed Web of Science ®Google Scholar
• AndersonJLVanwoerkomRCHorneBDParathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?Am Heart J20111622331339e221835295
   PubMed Web of Science ®Google Scholar
• RejnmarkLVestergaardPBrotCMosekildeLParathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristicsClin Endocrinol (Oxf)2008691293518208576
   PubMed Web of Science ®Google Scholar
• CurtisJREwingSKBauerDCAssociation of intact parathyroid hormone levels with subsequent hip BMD loss: the Osteoporotic Fractures in Men (MrOS) StudyJ Clin Endocrinol Metab20129761937194422442276
   PubMed Web of Science ®Google Scholar
• RejnmarkLVestergaardPBrotCMosekildeLIncreased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up studyCalcif Tissue Int201188323824521181400
   PubMed Web of Science ®Google Scholar
• BozicBLoncarGProdanovicNParathyroid hormone response to vitamin D insufficiency in elderly males with chronic heart failurePhysiol Res201160Suppl 1S155S16321777017
   PubMed Web of Science ®Google Scholar
• CawthonPMParimiNBarrett-ConnorESerum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older menJ Clin Endocrinol Metab201095104625463420631024
   PubMed Web of Science ®Google Scholar
• FisherAGohSSrikusalanukulWDavisMElevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacyCalcif Tissue Int200985430130919763373
   PubMed Web of Science ®Google Scholar
• BarbourKEHoustonDKCummingsSRCalciotropic hormones and the risk of hip and nonspine fractures in older adults: the Health ABC StudyJ Bone Miner Res20122751177118522228250
   PubMed Web of Science ®Google Scholar
• YamauchiMKajiHNawataKTakaokaSYamaguchiTSugimotoTRole of parathyroid hormone in bone fragility of postmenopausal women with vitamin D insufficiencyCalcif Tissue Int201188536236921287159
   PubMed Web of Science ®Google Scholar
• FloegeJKronenbergFFroissartMMortality in chronic kidney disease and mineral metabolismJAMA20113062159 author reply 159–16021750291
   PubMed Web of Science ®Google Scholar
• PottsJTParathyroid hormone: past and presentJ Endocrinol2005187331132516423810
   PubMed Web of Science ®Google Scholar
• GuerreiroPMRenfroJLPowerDMCanarioAVThe parathyroid hormone family of peptides: structure, tissue distribution, regulation, and potential functional roles in calcium and phosphate balance in fishAm J Physiol Regul Integr Comp Physiol20072922R679R69617023665
   PubMed Web of Science ®Google Scholar
• LiuYIbrahimASTayBHParathyroid hormone gene family in a cartilaginous fish, the elephant shark (Callorhinchus milii)J Bone Miner Res201125122613262320614475
   PubMed Web of Science ®Google Scholar
• BhattacharyaPYanYLPostlethwaitJRubinDAEvolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish developmentJ Endocrinol2011211218720021880859
   PubMed Web of Science ®Google Scholar
• PeirisANYoussefDGrantWBSecondary hyperparathyroidism: benign bystander or culpable contributor to adverse health outcomes?South Med J20121051364222189665
   PubMed Web of Science ®Google Scholar
• UrenaPKongXFAbou-SamraABParathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissuesEndocrinology199313326176238393771
   PubMed Web of Science ®Google Scholar
• UsdinTBBonnerTIHoareSRThe parathyroid hormone 2 (PTH2) receptorReceptors Channels200283–421121812529938
   PubMedGoogle Scholar
• OginoKBurkhoffDBilezikianJPThe hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related proteinEndocrinology19951367302430307789328
   PubMed Web of Science ®Google Scholar
• HaraMLiuYMZhenLPositive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potentialCirculation19979610370437099396474
   PubMed Web of Science ®Google Scholar
• BoginEHararyIThe relationship of calcium and parathyroid hormone in their effect on heart cellsMol Cell Biochem198777129353122019
   PubMed Web of Science ®Google Scholar
• ShimoyamaMOginoKFuruseYSignaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heartJ Cardiovasc Pharmacol200138449149911588519
   PubMed Web of Science ®Google Scholar
• PiovesanAMolineriNCasassoFLeft ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomyClin Endocrinol (Oxf)199950332132810435057
   PubMed Web of Science ®Google Scholar
• IwataSHyodoEYanagiSParathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patientsInt J Cardiol Epub June 24, 2011
   Web of Science ®Google Scholar
• MariniCGiustiMArmoninoRReduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imagingEur J Nucl Med Mol Imaging201037122256226320821006
   PubMed Web of Science ®Google Scholar
• RubinMRMaurerMSMcMahonDJBilezikianJPSilverbergSJArterial stiffness in mild primary hyperparathyroidismJ Clin Endocrinol Metab20059063326333015769995
   PubMed Web of Science ®Google Scholar
• WalkerMDSilverbergSJCardiovascular aspects of primary hyperparathyroidismJ Endocrinol Invest2008311092593119092300
   PubMed Web of Science ®Google Scholar
• YuNDonnanPTFlynnRWIncreased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)Clin Endocrinol (Oxf)2010731303420039887
   PubMed Web of Science ®Google Scholar
• HeyligerATangprichaVWeberCSharmaJParathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidismSurgery200914661042104719958931
   PubMed Web of Science ®Google Scholar
• CozzolinoMThe calciotropic hormones PTH and vitamin D: from bone to blood vesselsJ Intern Med2012271656656822211583
   PubMed Web of Science ®Google Scholar
• KamychevaESundsfjordJJordeRSerum parathyroid hormone levels predict coronary heart disease: the Tromso StudyEur J Cardiovasc Prev Rehabil2004111697415167209
   PubMedGoogle Scholar
• AhlströmTHagströmELarssonARudbergCLindLHellmanPCorrelation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and womenClin Endocrinol (Oxf)200971567367819250270
   PubMed Web of Science ®Google Scholar
• ChanRChanDWooJSerum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese menJ Hum Hypertens2012261202721248778
   PubMed Web of Science ®Google Scholar
• FraserAWilliamsDLawlorDAAssociations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006)PLoS One2010511e1388221085485
   PubMed Web of Science ®Google Scholar
• MorfisLSmerdelyPHowesLGRelationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressuresJ Hypertens19971511127112769383176
   PubMed Web of Science ®Google Scholar
• SnijderMBLipsPSeidellJCVitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and womenJ Intern Med2007261655856517547711
   PubMed Web of Science ®Google Scholar
• TaylorENCurhanGCFormanJPParathyroid hormone and the risk of incident hypertensionJ Hypertens20082671390139418551015
   PubMed Web of Science ®Google Scholar
• ZhaoGFordESLiCKris-EthertonPMEthertonTDBalluzLSIndependent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adultsJ Hypertens20102891821182820613627
   PubMed Web of Science ®Google Scholar
• LoncarGBozicBDimkovicSAssociation of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failureJ Endocrinol Invest2011343e78e8520820131
   PubMed Web of Science ®Google Scholar
• SchluterKDPiperHMCardiovascular actions of parathyroid hormone and parathyroid hormone-related peptideCardiovasc Res199837134419539855
   PubMed Web of Science ®Google Scholar
• McCartyMFBarroso-ArandaJContrerasFCan moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias?Med Hypotheses200972558158319188028
   PubMed Web of Science ®Google Scholar
• AlsafwahSLaguardiaSPNelsonMDHypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failureAm J Med Sci2008335429229718414068
   PubMed Web of Science ®Google Scholar
• AltayHZorluABiniciSRelation of serum parathyroid hormone level to severity of heart failureAm J Cardiol2012109225225621996143
   PubMed Web of Science ®Google Scholar
• KhouzamRNDishmonDAFarahVFlaxSDCarboneLDWeberKTSecondary hyperparathyroidism in patients with untreated and treated congestive heart failureAm J Med Sci20063311303416415661
   PubMed Web of Science ®Google Scholar
• ShaneEManciniDAaronsonKBone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failureAm J Med199710331972079316552
   PubMed Web of Science ®Google Scholar
• AlvarezJAAshrafAPHunterGRGowerBASerum 25--hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African AmericansAm J Clin Nutr20109261344134920861177
   PubMed Web of Science ®Google Scholar
• CovicAKothawalaPBernalMRobbinsSChalianAGoldsmithDSystematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney diseaseNephrol Dial Transplant20092451506152319001560
   PubMed Web of Science ®Google Scholar
• GaneshSKStackAGLevinNWHulbert-ShearonTPortFKAssociation of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patientsJ Am Soc Nephrol200112102131213811562412
   PubMed Web of Science ®Google Scholar
• CarlstedtFLindLWideLSerum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency departmentEur J Clin Invest199727129779819466123
   PubMed Web of Science ®Google Scholar
• PilzSTomaschitzADrechslerCParathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiographyEur Heart J201131131591159820439261
   PubMed Web of Science ®Google Scholar
• PremaorMOScalcoRda SilvaMJFurlanettoTWSecondary hyperparathyroidism is associated with increased risk of hospitalization or death in elderly adults living in a geriatric institutionGerontology200955440541019571528
   PubMed Web of Science ®Google Scholar
• AradYSpadaroLARothMSerum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography studyCoron Artery Dis1998985135189847983
   PubMed Web of Science ®Google Scholar
• HarnettJDKentGMBarrePETaylorRParfreyPSRisk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patientsJ Am Soc Nephrol199447148614908161730
   PubMed Web of Science ®Google Scholar
• WalkerMDFleischerJBDi TullioMRCardiac structure and diastolic function in mild primary hyperparathyroidismJ Clin Endocrinol Metab20109552172217920228165
   PubMed Web of Science ®Google Scholar
• KestenbaumBKatzRde BoerIVitamin D, parathyroid hormone, and cardiovascular events among older adultsJ Am Coll Cardiol201158141433144121939825
   PubMed Web of Science ®Google Scholar
• Fahrleitner-PammerAHerberthJBrowningSRBone markers predict cardiovascular events in chronic kidney diseaseJ Bone Miner Res200823111850185818597636
   PubMed Web of Science ®Google Scholar
• WilliamsDMFraserALawlorDAAssociations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescentsHeart201197431532021193684
   PubMed Web of Science ®Google Scholar
• FeldsteinCAAkopianMPietrobelliDOlivieriAGarridoDLong-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidismClin Exp Hypertens201032315415820504122
   PubMed Web of Science ®Google Scholar
• BrunnerSWeinbergerTHuberBCThe cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor releaseCardiovasc Res201093233033922080594
   PubMed Web of Science ®Google Scholar
• NickolsGAActions of parathyroid hormone in the cardiovascular systemBlood Vessels19872431201243036281
   PubMedGoogle Scholar
• ZarubaMMHuberBCBrunnerSParathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survivalCardiovasc Res200877472273118055578
   PubMed Web of Science ®Google Scholar
• AslanDAndersenMDGedeLBMechanisms for the bone anabolic effect of parathyroid hormone treatment in humansScand J Clin Lab Invest2012721142222085136
   PubMed Web of Science ®Google Scholar
• FeiYHurleyMMRole of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formationJ Cell Physiol2012227113539354522378151
   PubMed Web of Science ®Google Scholar
• MonegoGArenaVPasquiniSIschemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytesBasic Res Cardiol2009104442743419190955
   PubMed Web of Science ®Google Scholar
• RashidGBernheimJGreenJBenchetritSParathyroid hormone stimulates the endothelial expression of vascular endothelial growth factorEur J Clin Invest2008381179880319021696
   PubMed Web of Science ®Google Scholar
• RashidGPlotkinEKleinOGreenJBernheimJBenchetritSParathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and CAm J Physiol Renal Physiol20092961F60F6618945829
   PubMed Web of Science ®Google Scholar
• PotthoffSAJanusAHochHPTH-receptors regulate nor-epinephrine release in human heart and kidneyRegul Pept20111711–3354221756942
   PubMedGoogle Scholar
• UreñaJLópez-BarneoJMetabotropic regulation of RhoA/Rho-associated kinase by L-type Ca(2+) channelsTrends Cardiovasc Med201222615516022902183
   PubMed Web of Science ®Google Scholar
• BrunaudLGermainAZarnegarRSerum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidismSurgery200914661035104119958930
   PubMed Web of Science ®Google Scholar
• ChhokarVSSunYBhattacharyaSKHyperparathyroidism and the calcium paradox of aldosteronismCirculation2005111787187815710759
   PubMed Web of Science ®Google Scholar
• FritschSLindnerVWelschSIntravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responsesJ Am Soc Nephrol200415102588260015466263
   PubMed Web of Science ®Google Scholar
• LawPHSunYBhattacharyaSKChhokarVSWeberKTDiuretics and bone loss in rats with aldosteronismJ Am Coll Cardiol200546114214615992648
   PubMed Web of Science ®Google Scholar
• PilzSTomaschitzAMarzWCavalierERitzEAldosterone and parathyroid hormone: a complex and clinically relevant relationshipCalcif Tissue Int201087437337420721661
   PubMed Web of Science ®Google Scholar
• Rodríguez-AyalaEAvila-DíazMFoyo-NiembroEAmatoDRamirez-San-JuanEPaniaguaREffect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosteroneNephron Physiol20061033112118
   Google Scholar
• RutledgeMRFarahVAdeboyeAASeawellMRBhattacharyaSKWeberKTParathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronismCardiovasc Drugs Ther Epub February 29, 2012
   Web of Science ®Google Scholar
• TomaschitzARitzEPieskeBAldosterone and parathyroid hormone: a precarious couple for cardiovascular diseaseCardiovasc Res2012941101922334595
   PubMed Web of Science ®Google Scholar
• GoodmanWGThe consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney diseaseSemin Dial200417320921615144547
   PubMed Web of Science ®Google Scholar
• AkmalMKasimSESolimanARMassrySGExcess parathyroid hormone adversely affects lipid metabolism in chronic renal failureKidney Int19903738548582313975
   PubMed Web of Science ®Google Scholar
• LeeJHO’KeefeJHBellDHensrudDDHolickMFVitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?J Am Coll Cardiol200852241949195619055985
   PubMed Web of Science ®Google Scholar
• EastellRHannonRABiomarkers of bone health and osteoporosis riskProc Nutr Soc200867215716218412989
   PubMed Web of Science ®Google Scholar
• IbrahimSMojiminiyiSBarronJLPyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysisNephrol Dial Transplant19951012229022948808228
   PubMed Web of Science ®Google Scholar
• KnottLBaileyAJCollagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevanceBone19982231811879514209
   PubMed Web of Science ®Google Scholar
• NaylorKEastellRBone turnover markers: use in osteoporosisNat Rev Rheumatol20128737938922664836
   PubMed Web of Science ®Google Scholar
• PeichlPGriesmacherbAMarteauRSerum crosslaps in comparison to serum osteocalcin and urinary bone resorption markersClin Biochem200134213113911311223
   PubMed Web of Science ®Google Scholar
• RobinsSPWoitgeHHesleyRDirect, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorptionJ Bone Miner Res1994910164316497817812
   PubMed Web of Science ®Google Scholar
• ChapurlatRDGarneroPBreartGMeunierPJDelmasPDSerum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS studyBone200027228328610913923
   PubMed Web of Science ®Google Scholar
• ChopinFBiverEFunck-BrentanoTPrognostic interest of bone turnover markers in the management of postmenopausal osteoporosisJoint Bone Spine2012791263121723772
   PubMed Web of Science ®Google Scholar
• GerdhemPIvaskaKKAlataloSLBiochemical markers of bone metabolism and prediction of fracture in elderly womenJ Bone Miner Res200419338639315040826
   PubMed Web of Science ®Google Scholar
• CelikADavutogluVSaricaKRelationship between renal stone formation, mitral annular calcification and bone resorption markersAnn Saudi Med201030430130520622348
   PubMed Web of Science ®Google Scholar
• FassbenderWJGoddeMBrandenburgVMUsadelKHStumpfUCUrinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetesAdv Med Sci20095411619482729
   PubMed Web of Science ®Google Scholar
• LeliCPasqualiniLVaudoGCarotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagenIntern Emerg Med20105212713420182821
   PubMed Web of Science ®Google Scholar
• ManghatPSouleimanovaICheungJAssociation of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)Bone20114851127113221281749
   PubMed Web of Science ®Google Scholar
• Bar-ShavitZThe osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cellJ Cell Biochem200710251130113917955494
   PubMed Web of Science ®Google Scholar
• MasseyHMFlanaganAMHuman osteoclasts derive from CD14-positive monocytesBr J Haematol1999106116717010444181
   PubMed Web of Science ®Google Scholar
• JeziorskaMMcCollumCWoolleyDECalcification in atherosclerotic plaque of human carotid arteries: associations with mast cells and macrophagesJ Pathol1998185110179713354
   PubMed Web of Science ®Google Scholar
• MinHMoronySSarosiIOsteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesisJ Exp Med2000192446347410952716
   PubMed Web of Science ®Google Scholar
• MohlerER3rdGannonFReynoldsCZimmermanRKeaneMGKaplanFSBone formation and inflammation in cardiac valvesCirculation2001103111522152811257079
   PubMed Web of Science ®Google Scholar
• LaceyDLTimmsETanHLOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationCell19989321651769568710
   PubMed Web of Science ®Google Scholar
• D’AmelioPFornelliGRoatoIIsaiaGCInteractions between the immune system and boneWorld J Orthop201123253022474632
   PubMedGoogle Scholar
• DemerLTintutYThe roles of lipid oxidation products and receptor activator of nuclear factor-kappaB signaling in atherosclerotic calcificationCirc Res2011108121482149321659652
   PubMed Web of Science ®Google Scholar
• FengWLiWLiuWWangFLiYYanWIL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failureExp Mol Pathol200987321221819527710
   PubMed Web of Science ®Google Scholar
• HofbauerLCSchoppetMClinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseasesJAMA2004292449049515280347
   PubMed Web of Science ®Google Scholar
• KadenJJBickelhauptSGrobholzRReceptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcificationJ Mol Cell Cardiol2004361576614734048
   PubMed Web of Science ®Google Scholar
• KiechlSWernerPKnoflachMFurtnerMWilleitJSchettGThe osteoprotegerin/RANK/RANKL system: a bone key to vascular diseaseExpert Rev Cardiovasc Ther20064680181117173497
   PubMedGoogle Scholar
• SchoppetMAl-FakhriNFrankeFELocalization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg’s sclerosis and atherosclerosisJ Clin Endocrinol Metab20048984104411215292354
   PubMed Web of Science ®Google Scholar
• TakayanagiHOsteoimmunology and the effects of the immune system on boneNat Rev Rheumatol200951266767619884898
   PubMed Web of Science ®Google Scholar
• TintutYDemerLRole of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcificationJ Investig Med2006547395401
   Web of Science ®Google Scholar
• VegaDMaaloufNMSakhaeeKClinical review: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implicationsJ Clin Endocrinol Metab200792124514452117895323
   PubMed Web of Science ®Google Scholar
• VenurajuSMYerramasuACorderRLahiriAOsteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidityJ Am Coll Cardiol201055192049206120447527
   PubMed Web of Science ®Google Scholar
• HalapasAZacharoulisATheocharisSSerum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarctionClin Chem Lab Med200846451051618298349
   PubMed Web of Science ®Google Scholar
• MalligaDEWagnerDFahrleitner-PammerAThe role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology – a reviewWien Med Wochenschr201116123–2456557021870142
   PubMedGoogle Scholar
• YasunoriKMasaakiTTetsuyukiNHayatoKAkiraNReduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritisClin Rheumatol20082791093110118338203
   PubMed Web of Science ®Google Scholar
• BodinePVKommBSWnt signaling and osteoblastogenesisRev Endocr Metab Disord200671–2333916960757
   PubMed Web of Science ®Google Scholar
• de BorstMHVervloetMGter WeePMNavisGCross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney diseaseJ Am Soc Nephrol20112291603160921852584
   PubMed Web of Science ®Google Scholar
• JohnsonRCLeopoldJALoscalzoJVascular calcification: pathobiological mechanisms and clinical implicationsCirc Res200699101044105917095733
   PubMed Web of Science ®Google Scholar
• LópezIRodríguez-OrtizMEAlmadénYDirect and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivoKidney Int201180547548221525854
   PubMed Web of Science ®Google Scholar
• RheeYBiviNFarrowEParathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivoBone201149463664321726676
   PubMed Web of Science ®Google Scholar
• SageAPLuJAttiEHyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipidsJ Bone Miner Res20112661197120621611962
   PubMed Web of Science ®Google Scholar
• RobinsonADRamanathanKBMcGeeJENewmanKPWeberKTOxidative stress and cardiomyocyte necrosis with elevated serum troponins: pathophysiologic mechanismsAm J Med Sci2011342212913421747281
   PubMed Web of Science ®Google Scholar
• KamalovGBhattacharyaSKWeberKTCongestive heart failure: where homeostasis begets dyshomeostasisJ Cardiovasc Pharmacol201056332032820588190
   PubMed Web of Science ®Google Scholar
• KanekoKItoMFumotoTPhysiological function of the angiotensin AT1a receptor in bone remodelingJ Bone Miner Res201126122959296621887703
   PubMed Web of Science ®Google Scholar
• PolettiRVergaroGZywLPronteraCPassinoCEmdinMPrognostic value of plasma renin activity in heart failure patients with chronic kidney diseaseInt J Cardiol Epub March 27, 2012
   Web of Science ®Google Scholar
• SimJJShiJCalaraFRasgonSJacobsenSKalantar-ZadehKAssociation of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohortJ Hypertens201129112226223521941205
   PubMed Web of Science ®Google Scholar
• DanserAHThe increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor?Hypertens Res201033141019893565
   PubMed Web of Science ®Google Scholar
• JonesMRSealeyJELaraghJHEffects of angiotensin receptor blockers on ambulatory plasma renin activity in healthy, normal subjects during unrestricted sodium intakeAm J Hypertens200720890791617679042
   PubMed Web of Science ®Google Scholar
• StubbsJRWetmoreJBDoes it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism?Semin Dial201124329830621682772
   PubMed Web of Science ®Google Scholar
• LylesKWColón-EmericCSMagazinerJSZoledronic acid and clinical fractures and mortality after hip fractureN Engl J Med2007357181799180917878149
   PubMed Web of Science ®Google Scholar
• BeaupreLAMorrishDWHanleyDAOral bisphosphonates are associated with reduced mortality after hip fractureOsteoporos Int201122398399121052642
   PubMed Web of Science ®Google Scholar
• Colón-EmericCSMesenbrinkPLylesKWPotential mediators of the mortality reduction with zoledronic acid after hip fractureJ Bone Miner Res2010251919719580467
   PubMed Web of Science ®Google Scholar
• EriksenEFLylesKWColón-EmericCSAntifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fractureJ Bone Miner Res20092471308131319257818
   PubMed Web of Science ®Google Scholar
• SambrookPNCameronIDChenJSOral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year studyOsteoporos Int20112292551255620959963
   PubMed Web of Science ®Google Scholar
• JadhavSBJainGKStatins and osteoporosis: new role for old drugsJ Pharm Pharmacol200658131816393459
   PubMed Web of Science ®Google Scholar
• TangQOTranGTGamieZStatins: under investigation for increasing bone mineral density and augmenting fracture healingExpert Opin Investig Drugs2008171014351463
   PubMed Web of Science ®Google Scholar
• YangSNguyenNDEismanJANguyenTVAssociation between beta-blockers and fracture risk: a Bayesian meta-analysisBone201251596997422842220
   PubMed Web of Science ®Google Scholar